These findings suggest that ZMYND8 may facilitate breast cancer bone metastasis by regulating the expression of bone metastasis-related genes, highlighting its potential as a therapeutic target for inhibiting bone metastasis in breast cancer. Here, ZMYND8 is linked to breast carcinoma.